Evidence map›Paper›PMID 31623237›Full record

ArticlePharmaceuticals (Basel, Switzerland)2019

C3orf70 Is Involved in Neural and Neurobehavioral Development.

Yoshifumi Ashikawa, Takashi Shiromizu, Koki Miura, Yuka Adachi, Takaaki Matsui, Yasumasa Bessho, Toshio Tanaka, Yuhei Nishimura

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yoshifumi AshikawaDepartment of Integrative Pharmacology, Mie University Graduate School of Medicine, Tsu, Mie 514-8507, Japan. thegracioso1113@gmail.com.
Takashi ShiromizuDepartment of Integrative Pharmacology, Mie University Graduate School of Medicine, Tsu, Mie 514-8507, Japan. tshiromizu@doc.medic.mie-u.ac.jp.
Koki MiuraDepartment of Integrative Pharmacology, Mie University Graduate School of Medicine, Tsu, Mie 514-8507, Japan. 318090@m.mie-u.ac.jp.
Yuka AdachiDepartment of Integrative Pharmacology, Mie University Graduate School of Medicine, Tsu, Mie 514-8507, Japan. 319m001@m.mie-u.ac.jp.
Takaaki MatsuiGene Regulation Research, Graduate School of Biological Sciences, Nara Institute of Science and Technology, Takayama, Nara 630-0192, Japan. matsui@bs.naist.jp.
Yasumasa BesshoGene Regulation Research, Graduate School of Biological Sciences, Nara Institute of Science and Technology, Takayama, Nara 630-0192, Japan. ybessho@bs.naist.jp.
Toshio TanakaDepartment of Systems Pharmacology, Mie University Graduate School of Medicine, Tsu, Mie 514-8507, Japan.
Yuhei NishimuraDepartment of Integrative Pharmacology, Mie University Graduate School of Medicine, Tsu, Mie 514-8507, Japan. yuhei@doc.medic.mie-u.ac.jp.
Mie University · JPNara Institute of Science and Technology · JP

Funding

the Japan Society for the Promotion of Science KAKENHI 16K08547, 18K06890, 19K07318
6 · The paper itself

Abstract

Neurogenesis is the process by which undifferentiated progenitor cells develop into mature and functional neurons. Defects in neurogenesis are associated with neurodevelopmental and neuropsychiatric disorders; therefore, elucidating the molecular mechanisms underlying neurogenesis can advance our understanding of the pathophysiology of these disorders and facilitate the discovery of novel therapeutic targets. In this study, we performed a comparative transcriptomic analysis to identify common targets of the proneural transcription factors Neurog1/2 and Ascl1 during neurogenesis of human and mouse stem cells. We successfully identified C3orf70 as a novel common target gene of Neurog1/2 and Ascl1 during neurogenesis. Using in situ hybridization, we demonstrated that c3orf70a and c3orf70b, two orthologs of C3orf70, were expressed in the midbrain and hindbrain of zebrafish larvae. We generated c3orf70 knockout zebrafish using CRISPR/Cas9 technology and demonstrated that loss of c3orf70 resulted in significantly decreased expression of the mature neuron markers elavl3 and eno2. We also found that expression of irx3b, a zebrafish ortholog of IRX3 and a midbrain/hindbrain marker, was significantly reduced in c3orf70 knockout zebrafish. Finally, we demonstrated that neurobehaviors related to circadian rhythm and altered light-dark conditions were significantly impaired in c3orf70 knockout zebrafish. These results suggest that C3orf70 is involved in neural and neurobehavioral development and that defects in C3orf70 may be associated with midbrain/hindbrain-related neurodevelopmental and neuropsychiatric disorders.

Indexed as

comparative transcriptome analysisgene coexpression networkneurobehaviorneurogenesiszebrafish

Identifiers

PMID31623237
PMCPMC6958487
OpenAlexW2980557044

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.